✦ LIBER ✦

Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: Phase I study in Japanese patients with advanced solid malignancies and advanced breast cancer

✍ Scribed by Kurata, Takayasu; Tsurutani, Junji; Fujisaka, Yasuhito; Okamoto, Wataru; Hayashi, Hidetoshi; Kawakami, Hisato; Shin, Eisei; Hayashi, Nobuya; Nakagawa, Kazuhiko

Book ID: 125358953
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 314 KB
Volume: 32
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-014-0112-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I, dose-finding study of AZD8931,

Phase I, dose-finding study of AZD8931, an inhibitor of EGFR (erbB1), HER2 (erbB2) and HER3 (erbB3) signaling, in patients with advanced solid tumors

✍ Tjulandin, S.; Moiseyenko, V.; Semiglazov, V.; Manikhas, G.; Learoyd, M.; Saunde 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 313 KB

Phase I, dose-escalation study of AZD776

Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours

✍ Takashi Seto, Taito Esaki, Fumihiko Hirai… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 294 KB

A phase 2 study of everolimus combined w

A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy

✍ Hurvitz, Sara A.; Dalenc, Florence; Campone, Mario; OâRegan, Ruth M.; Tjan-Hei 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 327 KB

Phase I combination study of trabectedin

Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies

✍ Lia Gore, E. Rivera, M. Basche, S. L. Moulder-Thompson, J. Li, S. Eppers, S. Gro 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 159 KB

Phase II study of preoperative systemic

Phase II study of preoperative systemic treatment with the combination of docetaxel and trastuzumab in patients with locally advanced HER-2-overexpressing breast cancer

✍ Masataka Sawaki; Hiroji Iwata; Yasuyuki Sato; Masaki Wada; Tatsuya Toyama; Eiich 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 635 KB

Phase I Study of Oral Gemcitabine Prodru

Phase I Study of Oral Gemcitabine Prodrug (LY2334737) Alone and in Combination with Erlotinib in Patients with Advanced Solid Tumors

✍ Koolen, S. L. W.; Witteveen, P. O.; Jansen, R. S.; Langenberg, M. H. G.; Kroneme 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 378 KB